Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
NVO [NYSE]
Novo Nordisk A/S
Index- P/E26.54 EPS (ttm)1.73 Insider Own- Shs Outstand2.11B Perf Week1.75%
Market Cap96.85B Forward P/E22.34 EPS next Y2.06 Insider Trans- Shs Float2.01B Perf Month0.00%
Income4.62B PEG2.25 EPS next Q- Inst Own8.90% Short Float0.19% Perf Quarter1.84%
Sales15.12B P/S6.41 EPS this Y20.40% Inst Trans0.11% Short Ratio4.47 Perf Half Y24.52%
Book/sh2.32 P/B19.79 EPS next Y11.56% ROA38.60% Target Price49.37 Perf Year39.33%
Cash/sh0.45 P/C102.73 EPS next 5Y11.80% ROE68.10% 52W Range31.61 - 47.53 Perf YTD26.58%
Dividend0.61 P/FCF70.53 EPS past 5Y24.60% ROI56.40% 52W High-3.40% Beta0.98
Dividend %1.33% Quick Ratio0.90 Sales past 5Y12.90% Gross Margin83.30% 52W Low45.25% ATR0.52
Employees39579 Current Ratio1.30 Sales Q/Q1.80% Oper. Margin38.10% RSI (14)56.34 Volatility0.87% 0.85%
OptionableYes Debt/Eq0.02 EPS Q/Q10.00% Profit Margin31.00% Rel Volume0.56 Prev Close45.91
ShortableYes LT Debt/Eq0.00 EarningsFeb 02 BMO Payout33.70% Avg Volume867.23K Price45.91
Recom2.00 SMA200.20% SMA502.61% SMA20012.58% Volume501,100 Change0.00%
28-May-13Upgrade Deutsche Bank Sell → Hold
31-Mar-10Initiated Deutsche Bank Hold
30-Mar-10Downgrade Mehta Partners Outperform → Market Perform
24-Feb-10Upgrade Jefferies & Co Hold → Buy
15-Jan-10Downgrade Jefferies & Co Buy → Hold
11-Sep-09Initiated Jefferies & Co Buy
07-Aug-09Downgrade UBS Buy → Neutral
07-Aug-09Downgrade JP Morgan Overweight → Neutral
12-May-09Initiated Piper Jaffray Buy
24-Apr-09Upgrade Citigroup Hold → Buy
26-Mar-09Upgrade UBS Neutral → Buy
14-Jan-09Downgrade Citigroup Hold → Sell
06-Oct-08Upgrade Deutsche Securities Hold → Buy
29-Aug-08Downgrade Bernstein Mkt Perform → Underperform
21-Aug-08Initiated UBS Neutral
09-Jun-08Upgrade HSBC Securities Underweight → Neutral
26-Feb-08Downgrade Bear Stearns Outperform → Peer Perform
08-Feb-08Upgrade Bernstein Mkt Perform → Outperform
23-Jan-08Upgrade Bear Stearns Peer Perform → Outperform
09-Aug-07Downgrade Lehman Brothers Overweight → Equal-weight
25-Jul-14 07:30AM  Novo Nordisk receives positive opinion from CHMP at theflyonthewall.com
07:23AM  EMA recommends approval for Novo Nordisk diabetes treatment at theflyonthewall.com
17-Jul-14 08:49AM  [video] Paying for diabetes pandemic at CNBC
16-Jul-14 01:03PM  3 Stocks Advancing The Drugs Industry at TheStreet
11-Jul-14 05:18PM  Is This MannKind's Greatest Risk? at Motley Fool
08-Jul-14 05:40PM  Sanofi's Basal Insulin Candidate Under FDA Review Zacks
10:30AM  Can Dividend Stocks Novo Nordisk and Novartis Continue to Perform? at Motley Fool
10:30AM  Novo Nordisk Gets FDA Nod for NovoSeven RT Zacks
07-Jul-14 06:18PM  Jazz, Novo Among Medicals Showing Healthy Action at Investor's Business Daily
05:03AM  1 Key Question Remains after MannKind's Giant Leap at Motley Fool
05-Jul-14 05:00PM  3 Things to Look for in MannKind's Partnership at Motley Fool
30-Jun-14 05:00PM  Biogen Hemophilia Drugs Launch Into The Unknown at Investor's Business Daily
04:32PM  MannKind's Afrezza Approved but Will Doctors Prescribe It? at Motley Fool
02:02PM  MannKind Stock: Afrezza Approved at Last, But Will Sales Disappoint? at Motley Fool
11:06AM  Up 9%: What You Need to Know About MannKind Today at Motley Fool
10:38AM  Consider Shire Pharmaceuticals Now; 20%+ Upside Left In Takeover Bid By AbbVie at Seeking Alpha
27-Jun-14 02:22AM  MannKind's Clock Is Ticking, But Balance Sheet Sounds An Alarm at Seeking Alpha
02:22AM  MannKind's Clock Is Ticking, But Balance Sheet Sounds An Alarm
26-Jun-14 06:41PM  Novo, Other Medicals Display Healthy Action at Investor's Business Daily
06:41PM  Novo, Other Medicals Display Healthy Action
06:05PM  Novo Nordisk's Diabetes Pill Shows Promise at Seeking Alpha
06:05PM  Novo Nordisk's Diabetes Pill Shows Promise
24-Jun-14 11:00AM  Team Novo Nordisk, the world's first all-diabetes professional cycling team, races in BC Superweek CNW Group
11:00AM  Team Novo Nordisk, the world's first all-diabetes professional cycling team, races in BC Superweek
01:11AM  Is Sanofi's Dividend Safe? at Motley Fool
01:11AM  Is Sanofi's Dividend Safe?
23-Jun-14 04:32PM  Sanofi: Toujeo Is Not The Ace In Its Deck at Seeking Alpha
04:32PM  Sanofi: Toujeo Is Not The Ace In Its Deck
10:30AM  Novo Nordisk Reveals Positive Data on Victoza 3 mg Zacks
10:30AM  Novo Nordisk Reveals Positive Data on Victoza 3 mg
12:01AM  Early Results Arrive on Weight-Loss Pills That Expand in the Stomach at New York Times
12:01AM  Early Results Arrive on Weight-Loss Pills That Expand in the Stomach
20-Jun-14 06:24PM  Who Will Win This $45 Billion Market? at Motley Fool
06:24PM  Who Will Win This $45 Billion Market?
02:32PM  Health Insurers Pressing Down on Drug Prices at New York Times
02:32PM  Health Insurers Pressing Down on Drug Prices
11:34AM  The Anti-Obesity Space Is Not As Simple As Some Think at Seeking Alpha
11:34AM  The Anti-Obesity Space Is Not As Simple As Some Think
18-Jun-14 04:34PM  Is Novo Nordisk's Dividend Safe? at Motley Fool
04:34PM  Is Novo Nordisk's Dividend Safe?
03:30PM  A Cost of Doing Business? How Regulatory Fines Hurt Shareholder Returns at The Wall Street Journal
03:30PM  A Cost of Doing Business? How Regulatory Fines Hurt Shareholder Returns
08:46AM  Novo Nordisk (NVO) is in Overbought Territory: What's Next? Zacks
08:46AM  Novo Nordisk (NVO) is in Overbought Territory: What's Next?
17-Jun-14 03:35PM  Ligand Pharma's LGD-6972 Positive in Phase I Study Zacks
03:35PM  Ligand Pharma's LGD-6972 Positive in Phase I Study
12:34AM  [$$] Novo Nordisk Sees 'No Strategic Reason' For Big Mergers at The Wall Street Journal
12:34AM  [$$] Novo Nordisk Sees 'No Strategic Reason' For Big Mergers
16-Jun-14 11:15PM  [$$] Novo Nordisk Sees 'No Strategic Reason' For Big Mergers at The Wall Street Journal
09:13PM  [$$] Novo Nordisk Sees 'No Strategic Reason' For Big Mergers at The Wall Street Journal
03:45PM  Novo Nordisk's Victoza 3 mg Positive in Phase III Zacks
03:45PM  Novo Nordisk's Victoza 3 mg Positive in Phase III
03:30PM  Sanofi's Diabetes Portfolio in Focus at American Diabetes Association Sessions Zacks
03:30PM  Sanofi's Diabetes Portfolio in Focus at American Diabetes Association Sessions
10:10AM  Eli Lilly Impresses at American Diabetes Association Sessions Zacks
10:10AM  Eli Lilly Impresses at American Diabetes Association Sessions
07:25AM  [$$] Novo Nordisk Sees 'No Strategic Reason' For Big Mergers at The Wall Street Journal
06:52AM  [$$] Novo Nordisk Sees 'No Strategic Reason' For Big Mergers at The Wall Street Journal
15-Jun-14 03:48PM  Will These 3 Products Revolutionize Diabetes Treatment? at Motley Fool
14-Jun-14 01:27AM  The 3 Best Big Pharma Dividend Stocks of the Past 10 Years at Motley Fool
13-Jun-14 05:29PM  Novo Nordisk Raises Insulin Prices As Demand Grows at Investor's Business Daily
02:56PM  Vivus Suit Preserves Exclusivity Of Qsymia - For Now at Seeking Alpha
01:41PM  [video] The diabetes battleground at CNBC
09:24AM  Is Eli Lilly's Dividend Safe? at Motley Fool
09:22AM  Stock Downgrades: Another Kick in the Pants for Lululemon at Minyanville
11-Jun-14 07:46PM  MannKind Corporation's Date With Destiny at Motley Fool
10-Jun-14 01:02PM  Today's Stocks Driving Success For The Health Care Sector at TheStreet
06-Jun-14 11:33AM  5 Toxic Big Pharma Stocks You Need to Sell This Summer at TheStreet
07:00AM  MannKind Hits 52-Week High Zacks
04-Jun-14 07:00AM  Qu├ębec Becomes First Province to Add Victoza┬« to the Drug Benefit Formulary* for the Treatment of Type 2 Diabetes PR Newswire
03-Jun-14 06:32PM  The Importance Of Being Oral at Seeking Alpha
27-May-14 06:32PM  Is Biogen Idec Inc a Buy? at Motley Fool
23-May-14 11:45AM  Novo Nordisk to host conference call at theflyonthewall.com
22-May-14 08:01AM  Norway's Exemplary Gender Quota? Just Don't Ask About CEOs at The Wall Street Journal
21-May-14 04:35PM  FDA Panel to Review Novo Nordisk's Victoza 3mg Zacks
20-May-14 08:20AM  Citigroup to hold a conference at theflyonthewall.com
19-May-14 04:39PM  Investors Should Cheer Novo Nordisk Study Results at Seeking Alpha
16-May-14 04:30PM  Data on Novo Nordisk's NovoEight Zacks
14-May-14 07:12AM  Novo Nordisk downgraded to Neutral from Buy at UBS at theflyonthewall.com
13-May-14 10:10AM  Wider-than-Expected Q1 Loss at MannKind Zacks
12-May-14 04:27PM  Google Celebrates Dorothy Hodgkin & Her Contributions To Chemistry Benzinga
12:04PM  Eli Lilly's Basal Insulin Outperforms Lantus In Trial at Investor's Business Daily
07:59AM  Novo Nordisk announces DKK 15B share repurchase program at theflyonthewall.com
10-May-14 03:16PM  MannKind Corporation Earnings: Are Better Times Ahead? at Motley Fool
08-May-14 01:03PM  3 Stocks Dragging The Drugs Industry Downward at TheStreet
02-May-14 10:10AM  Novo Nordisk Beats Earnings Ests, Misses Revs Zacks
07:32AM  Novel Treatment Innovations Continue to Drive Biotech Sector Success Stories: A Wall Street Transcript Interview with Brian Skorney, Senior Analyst with Robert W. Baird & Co. Wall Street Transcript
01-May-14 06:32PM  Are Investors Putting Too Much Faith In Novo Nordisk? at Motley Fool
05:01PM  Novo Nordisk Struggles In U.S. Market; Q1 Sales Miss at Investor's Business Daily
11:48AM  Novo Nordisk Q1 Revenue Misses; Guidance Lowered at Investor's Business Daily
11:03AM  FDA Acceptance of Smaller Clinical Trials Offers Upside to Biotech Stocks: Exclusive Interview with David Nierengarten, Ph.D., an Analyst at Wedbush Securities Covering the Biotechnology and Biopharmaceuticals Sector Wall Street Transcript
04:55AM  [$$] Novo Nordisk Lowers Sales Forecasts at The Wall Street Journal
04:24AM  Novo Nordisk profit up 8%; warns on sales growth at MarketWatch
02:40AM  [$$] Novo Nordisk Profit Rises 8% at The Wall Street Journal
02:11AM  [$$] Novo Nordisk Quarterly Profit Rises 8% at The Wall Street Journal
29-Apr-14 03:50PM  Is AstraZeneca Really Worth $100 Billion? at Motley Fool
28-Apr-14 03:10PM  A Wall Street Transcript Interview with Andrew Baum, M.D., Citigroup Investment Global Head of Healthcare Research & Analysis: Faster FDA Approvals and Paradigm-Shifting Breakthroughs Boost Pharma Stocks Wall Street Transcript
27-Apr-14 10:32AM  Can Marijuana Treat Diabetes? at Motley Fool
25-Apr-14 11:39AM  Wall Street Transcript Interview with Thomas B. King, the President, CEO and Director of Alexza Pharmaceutical, Inc. (ALXA) Wall Street Transcript
24-Apr-14 04:30PM  Biodel, HEC Pharm Ink Deal Zacks
Novo Nordisk A/S engages in the discovery, development, manufacture, and marketing of pharmaceutical products primarily in Denmark. It operates in two segments, Diabetes Care and Biopharmaceuticals. The Diabetes Care segment covers insulins, GLP-1 analog, obesity, and oral antidiabetic drugs, as well as other protein related products comprising glucagon, protein related delivery systems, and needles. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth hormone therapy, hormone replacement therapy, and inflammation. The company sells its products primarily in North America, China, Japan, Algeria, Argentina, Australia, Brazil, India, Turkey, and European countries through its subsidiaries, distributors, and independent agents. Novo Nordisk A/S was founded in 1925 and is headquartered in Bagsvaerd, Denmark.